Dmitriy Sonkin
Overview
Explore the profile of Dmitriy Sonkin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
7021
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karchin R, Radivojac P, ODonnell-Luria A, Greenblatt M, Tolstorukov M, Sonkin D
Nat Genet
. 2024 Jul;
56(7):1324-1326.
PMID: 38956207
No abstract available.
2.
Sonkin D, Thomas A, Teicher B
Cancer Genet
. 2024 Jun;
286-287:18-24.
PMID: 38909530
There is a rich history of cancer treatments which provides a number of important lessons for present and future cancer therapies. We outline this history by looking in the past,...
3.
Morris J, Kunkel M, White S, Wishka D, Lopez O, Bowles L, et al.
Mol Cancer Ther
. 2023 Aug;
22(11):1270-1279.
PMID: 37550087
The NCI-60 human tumor cell line panel has proved to be a useful tool for the global cancer research community in the search for novel chemotherapeutics. The publicly available cell...
4.
Horak P, Griffith M, Danos A, Pitel B, Madhavan S, Liu X, et al.
Genet Med
. 2022 Sep;
24(9):1991.
PMID: 36063163
No abstract available.
5.
Horak P, Chakravarty D, Sonkin D
Genet Med
. 2022 Jul;
24(9):1989-1990.
PMID: 35796744
No abstract available.
6.
Horak P, Griffith M, Danos A, Pitel B, Madhavan S, Liu X, et al.
Genet Med
. 2022 Feb;
24(5):986-998.
PMID: 35101336
Purpose: Several professional societies have published guidelines for the clinical interpretation of somatic variants, which specifically address diagnostic, prognostic, and therapeutic implications. Although these guidelines for the clinical interpretation of...
7.
Vural S, Chang L, Yee L, Sonkin D
Sci Rep
. 2021 Aug;
11(1):17275.
PMID: 34446762
TP53 is one of the most frequently altered genes in cancer; it can be inactivated by a number of different mechanisms. NM_000546.6 (ENST00000269305.9) is by far the predominant TP53 isoform,...
8.
Palmisano A, Vural S, Zhao Y, Sonkin D
Hum Mutat
. 2021 Feb;
42(4):342-345.
PMID: 33600011
Splice site variants may lead to transcript alterations, causing exons inclusion, exclusion, truncation, or intron retention. Interpreting the consequences of a specific splice site variant is not straightforward, especially if...
9.
Krushkal J, Silvers T, Reinhold W, Sonkin D, Vural S, Connelly J, et al.
Clin Epigenetics
. 2020 Jun;
12(1):93.
PMID: 32586373
Background: Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer. SCLC progression and treatment resistance involve epigenetic processes. However, links between SCLC DNA methylation and drug response remain...
10.
Wagner A, Walsh B, Mayfield G, Tamborero D, Sonkin D, Krysiak K, et al.
Nat Genet
. 2020 Apr;
52(4):448-457.
PMID: 32246132
Precision oncology relies on accurate discovery and interpretation of genomic variants, enabling individualized diagnosis, prognosis and therapy selection. We found that six prominent somatic cancer variant knowledgebases were highly disparate...